Latest Breaking News On - Pharmaceuticals wuxi co ltd - Page 1 : comparemela.com

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesRui zhangPharmaceuticals wuxi co ltdExchange commissionPharmaceuticals china co ltdDrug administrationEuropean medicines agencyPharmaceuticals incNational medical products administrationImmune thrombocytopeniaGreater chinaSecurities litigation reform actNasdaq capital marketMedical products administration

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRui zhangEuropean medicines agencyPharmaceuticals china co ltdPharmaceuticals wuxi co ltdPharmaceuticals incNational medical products administrationAcrotech biopharma incExchange commissionDrug administrationLooking statementsSecurities litigation reform actNasdaq capital marketMedical products administrationAcrotech biopharma

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

BEIJING, April 8, 2024 /PRNewswire/ CASI Pharmaceuticals, Inc. , a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and.

United statesRui zhangExchange commissionEuropean medicines agencyPharmaceuticals wuxi co ltdPharmaceuticals incNational medical products administrationDrug administrationAcrotech biopharma incPharmaceuticals china co ltdGreater chinaLooking statementsSecurities litigation reform actNasdaq capital marketMedical products administrationAcrotech biopharma

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

/PRNewswire/ CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative.

United statesRui zhangExchange commissionAcrotech biopharma incDrug administrationNational medical products administrationEuropean medicines agencyPharmaceuticals wuxi co ltdPharmaceuticals china co ltdPharmaceuticals incGreater chinaLooking statementsSecurities litigation reform actNasdaq capital marketMedical products administrationAcrotech biopharma

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRepublic of chinaTaiwan generalUnited kingdomHong kongJuventa inaticabtagene autoleucelRui zhangInaticabtagene autoleucelPharmaceuticals china co ltdAcrotech biopharma incMundipharma international corporation limitedChina national medical products administrationEuropean medicines agencyMundipharma medical company mmcoDrug administrationPharmaceuticals wuxi co ltd